Rops AL, Gotte M, Baselmans MH, van den Hoven MJ, Steenbergen EJ, Lensen JF, Wijnhoven TJ, Cevikbas F, van den Heuvel LP, van Kuppevelt TH, Berden JH, van der Vlag J
Research article (journal)During the heterologous phase of experimental anti-glomerular basement membrane (anti-GBM) nephritis, leukocyte influx peaks within hours, whereas albuminuria occurs within 1 day. In the subsequent autologous phase, endogenous anti-GBM IgG develops and albuminuria persists. Heparan sulfate (HS) proteoglycans like syndecan-1 play multiple roles during inflammation and we evaluate its role in experimental anti-GBM disease using syndecan-1 knockout (sdc-1(-/-)) mice. During the heterologous phase, glomerular leukocyte/macrophage influx was significantly higher in the sdc-1(-/-) mice and this was associated with higher glomerular endothelial expression of specific HS domains. In the autologous phase, glomerular influx of CD4+/CD8+ T cells was higher in the sdc-1(-/-) mice and these mice had persistently higher albuminuria and serum creatinine levels than wild-type mice. This resulted in a more sever glomerular injury and increased expression of extracellular matrix proteins. The sdc-1(-/-) mice developed higher plasma levels and glomerular deposits of total mouse Ig and IgG1 anti-rabbit IgG, whereas the levels of mouse IgG2a anti-rabbit IgG were lower. Furthermore, decreased Th1 and higher Th2 renal cytokine/chemokine expression were found in the sdc-1(-/-) mice. Our studies show that syndecan-1 deficiency exacerbates anti-GBM nephritis shifting the Th1/Th2 balance towards a Th2 response.
| Götte, Martin | Department of Gynecology and Obstetrics |
Duration: 01/01/2010 - 31/12/2012 Funded by: German-Israeli Foundation for Scientific Research and Development Type of project: Individual project | |
Duration: 01/01/2010 - 31/12/2010 | 1st Funding period Funded by: DFG - Initiation of International Collaboration Type of project: Individual project |
Role of the heparan sulfate proteoglycan Syndecan-1 as a modulator of inflammation and tumor progression Candidate: Götte, Martin | Reviewers: Kiesel, LudwigPeriod of time: 01/01/2008 - 12/04/2011 Habilitation procedure finished at: Habilitation procedure at University of Münster |